Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: comparison of three homogeneous methods

被引:40
作者
Sakaue, T
Hirano, T
Yoshino, G
Sakai, K
Takeuchi, H
Adachi, M
机构
[1] Showa Univ, Sch Med, Dept Internal Med 1, Shinagawa Ku, Tokyo 142, Japan
[2] Toho Univ, Sch Med, Dept Lab Med, Tokyo, Japan
关键词
direct LDL-cholesterol assay; homogeneous method; IDL; VLDL; type III dysbetalipoproteinemia;
D O I
10.1016/S0009-8981(00)00200-X
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
According to the definition of the Lipid Research Clinic's protocol, low-density lipoprotein (LDL) refers to the lipoprotein of density (d)=1.006-1.063 g/ml which contains another atherogenic lipoprotein, IDL (d = 1.006-1.019 g/ml). Because metabolic properties are largely different between LDL and IDL, LDL is now defined as the lipoprotein of d = 1.019-1.063 g/ml. Recently direct LDL-cholesterol assay kits using novel surfactants (the homogeneous methods) have become commercially available and widely used in Japan. The aim of this study is to examine how three direct LDL-cholesterol assay kits, LDL-EX, Choletest-LDL and Determinor-L LDL, react with pure LDL (d = 1.019-1.063 g/ml) and IDL (1.006-1.019 g/ml) fractions isolated by ultracentrifugation. Thirty-one healthy subjects and one type III dysbetalipoproteinemic patient were enrolled in this study. All homogeneous methods highly correlated with LDL-cholesterol (r=0.95-0.98), although the values for LDL-EX were closer to the values for ultracentrifugation than were those of the other two methods (95 vs. 86-87%, P < 0.0001). Cross-reactivity with IDL was 31, 47 and 64% for LDL-EX, Choletest-LDL, and Determinor-L LDL, respectively. Similar results were obtained in the IDL from a type UI dysbetalipoproteinemic patient. These results suggest that LDL-cholesterol measured by LDL-EX better reflects pure LDL fraction with weaker cross-reaction with IDL than other homogeneous methods. Elsevier Science B.V. (C) 2000 All rights reserved.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 10 条
[1]  
FREIDEWALD WT, 1972, CLIN CHEM, V18, P499
[2]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[3]   Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness [J].
Hodis, HN ;
Mack, WJ ;
Dunn, M ;
Liu, CR ;
Selzer, RH ;
Krauss, RM .
CIRCULATION, 1997, 95 (08) :2022-2026
[4]  
*MAN LAB OP LIP RE, 1974, DHEW PUBL
[5]  
MARLEY RW, 1995, METABOLIC MOL BASIS, P1953
[6]  
Nakamura M., 1997, Clinical Chemistry, V43, pS260
[7]   Low-density lipoprotein cholesterol can be chemically measured: A new superior method [J].
Okada, M ;
Matsui, H ;
Ito, Y ;
Fujiwara, A ;
Inano, K .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 132 (03) :195-201
[8]  
Sugiuchi H, 1998, CLIN CHEM, V44, P522
[9]   IDL composition and angiographically determined progression of atherosclerotic lesions during simvastatin therapy [J].
Sutherland, WH ;
Restieaux, NJ ;
Nye, ER ;
Williams, MJA ;
de Jong, SA ;
Robertson, MG ;
Walker, HL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) :577-583
[10]   INTERMEDIATE-DENSITY LIPOPROTEIN AND CHOLESTEROL-RICH VERY LOW-DENSITY LIPOPROTEIN IN ANGIOGRAPHICALLY DETERMINED CORONARY-ARTERY DISEASE [J].
TATAMI, R ;
MABUCHI, H ;
UEDA, K ;
UEDA, R ;
HABA, T ;
KAMETANI, T ;
ITO, S ;
KOIZUMI, J ;
OHTA, M ;
MIYAMOTO, S ;
NAKAYAMA, A ;
KANAYA, H ;
OIWAKE, H ;
GENDA, A ;
TAKEDA, R .
CIRCULATION, 1981, 64 (06) :1174-1184